LUNG CANCER
Frances A. Shepherd, MD
Princess Margaret Hospital
- Frances A. Shepherd, MD, is the Scott Taylor Chair in Lung Cancer Research and a senior staff physician at the Princess Margaret Cancer Centre in Toronto, Canada, and a professor of Medicine at the University of Toronto.
- Developing and evaluating new and combined modality treatment strategies at the local, national, and international levels for patients with small cell and non–small cell lung cancers.
- Worked with Emil J. Freireich, MD, to develop the POMP chemotherapy combination of methotrexate, mercaptopurine, vincristine, and prednisone for children with acute lymphoblastic leukemia.
- Spearheads development of international phase III studies in collaboration with cooperative groups and institutions throughout North America and Europe.
- Helped conduct landmark international NCIC BR. 21 trial that confirmed for the first time a survival benefit with an EGFR inhibitor, erlotinib, in patients with non–small cell lung cancer.
- Chaired National Cancer Institute of Canada’s Clinical Trials Group Lung Cancer Site for 19 years, during which the program earned the highest rankings in 3 external reviews.
- Recognized with numerous awards, including the Order of Ontario in 2007, and the British Thoracic Oncology Group International Award for Contributions to Lung Cancer and a Queen Elizabeth II Diamond Jubilee medal in 2012.
